AlisonTStopeckMD
Oncology • Stony Brook, NYAssociate Professor of Medicine, University Ariz College of Medicine
Dr. Stopeck is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Nicolls Rd
Stony Brook, NY 11794
Education & Training
New York-Presbyterian HospitalFellowship, 1988 - 1991- New York-Presbyterian HospitalResidency, 1985 - 1988
Columbia University Vagelos College of Physicians and SurgeonsClass of 1985
Certifications & Licensure
NY State Medical License 2022 - 2026
AZ State Medical License 1993 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 48 citationsCost-effectiveness of denosumab vs zoledronic acid for prevention of skeletal-related events in patients with solid tumors and bone metastases in the United StatesAlison Stopeck, Michael Rader, David H. Henry, Mark D. Danese, Marc Halperin
Journal of Medical Economics. 2012-03-12 - 1034 citationsDenosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind StudyAlison Stopeck, Allan Lipton, Jean-Jacques Body, Guenther G. Steger, Katia Tonkin
Journal of Clinical Oncology. 2010-12-10 - 11 citationsResponse to letter to the Editors-Safety of long-term denosumab therapy.Alison Stopeck, Douglas Warner
Supportive Care in Cancer. 2017-02-01
Press Mentions
Integrative Care for Breast Cancer PatientsOctober 2nd, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
